Gene · 54
Papers2,683
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,683
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
The Impact of a 6-Week Nordic Walking Training Cycle and a 14-Hour Intermittent Fasting on Disease Activity Markers and Serum Levels of Wnt Pathway-Associated Proteins in Patients with Multiple Myeloma. | J Clin Med | 2024 | 38792313 | PubTator, text mining | PubMed |
| Detection of genetic mutations underlying early-onset systemic lupus erythematosus. | Lupus | 2024 | 38739464 | PubTator, text mining | PubMed |
| Dairy consumption, bone turnover biomarkers, and osteo sono assessment index in Japanese adults: A cross-sectional analysis of data from the Iwaki Health Promotion Project. | Bone Rep | 2024 | 38736771 | PubTator, text mining | PubMed |
| scEWE: high-order element-wise weighted ensemble clustering for heterogeneity analysis of single-cell RNA-sequencing data. | Brief Bioinform | 2024 | 38701413 | PubTator, text mining | PubMed |
| Clinical Efficacy of Bisphosphonates in Treating Osteoporosis in Diabetes Patients: A Meta-Analysis. | Horm Metab Res | 2024 | 38670123 | PubTator, text mining | PubMed |
| The Expression and Secretion Profile of TRAP5 Isoforms in Gaucher Disease. | Cells | 2024 | 38667330 | PubTator, text mining | PubMed |
| Changes in Testing and Treatment Methods in Osteoporosis Care. | J Osteoporos | 2024 | 38659619 | PubTator, text mining | PubMed |
| Effects of sodium-glucose cotransporter 2 inhibitors on bone metabolism in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. | BMC Endocr Disord | 2024 | 38658986 | PubTator, text mining | PubMed |
| Prognostic value of serum tartrate‑resistant acid phosphatase‑5b for bone metastasis in patients with resectable breast cancer. | Oncol Lett | 2024 | 38638841 | PubTator, text mining | PubMed |
| Prolonged bone health benefits for breast cancer patients following adjuvant bisphosphonate therapy: the BoHFAB study. | J Bone Miner Res | 2024 | 38630878 | PubTator, text mining | PubMed |
| Discordant responses of bone formation and absorption markers in Japanese infants with vitamin D deficiency: a comprehensive matched case-control study. | JBMR Plus | 2024 | 38623484 | PubTator, text mining | PubMed |
| A common multi-host parasite shows genetic structuring at the host species and population levels. | Parasitology | 2024 | 38616414 | PubTator, text mining | PubMed |
| High-throughput diagnostic markers for foliar fungal disease resistance and high oleic acid content in groundnut. | BMC Plant Biol | 2024 | 38594614 | PubTator, text mining | PubMed |
| Autoimmune Hemolytic Anemia Due to Spondyloenchondrodysplasia with Spastic Paraparesis and Intracranial Calcification due to Mutation in ACP5. | J Pediatr Genet | 2024 | 38567175 | PubTator, text mining | PubMed |
| Cycloastragenol prevents bone loss via inhibiting osteoclast activity in glucocorticoid-induced osteonecrosis of the femoral head: An in vivo study. | J Orthop Translat | 2024 | 38549807 | PubTator, text mining | PubMed |
| Exposure to per- and polyfluoroalkyl substances and high-throughput proteomics in Hispanic youth. | Environ Int | 2024 | 38537583 | PubTator, text mining | PubMed |
| Reducing Re-fractures Post Percutaneous Kyphoplasty: The Impact of Zoledronic Acid with Calcium and Vitamin D3 in Osteoporotic Patients. | Altern Ther Health Med | 2024 | 38518159 | PubTator, text mining | PubMed |
| Long-term effects of denosumab on bone mineral density and turnover markers in patients undergoing hemodialysis. | J Bone Miner Metab | 2024 | 38512458 | PubTator, text mining | PubMed |
| Association of serum sodium levels with fractures and mortality in patients undergoing maintenance hemodialysis. | J Nephrol | 2024 | 38512372 | PubTator, text mining | PubMed |
| Transcriptomic and proteomic study of cancer cell lines exposed to actinomycin D and nutlin-3a reveals numerous, novel candidates for p53-regulated genes. | Chem Biol Interact | 2024 | 38460933 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54/papers?page=12